Authors:
IMANIDIS G
HELBINGSTRAUSAK S
IMBODEN R
LEUENBERGER H
Citation: G. Imanidis et al., VEHICLE-DEPENDENT IN-SITU MODIFICATION OF MEMBRANE-CONTROLLED DRUG-RELEASE, Journal of controlled release, 51(1), 1998, pp. 23-34
Authors:
GEMPELER M
WIKSTROM P
MEIER J
IMANIDIS G
LEUENBERGER H
Citation: M. Gempeler et al., PERMEATION OF 3-AMIDINOPHENYLALANINE DERIVED THROMBIN INHIBITORS IN IN-VITRO CACO-2 CELL-CULTURE MODEL, Thrombosis and haemostasis, 1997, pp. 2035-2035
Authors:
IMANIDIS G
WALDNER C
METTLER C
LEUENBERGER H
Citation: G. Imanidis et al., AN IMPROVED DIFFUSION CELL DESIGN FOR DETERMINING DRUG TRANSPORT PARAMETERS ACROSS CULTURED-CELL MONOLAYERS, Journal of pharmaceutical sciences, 85(11), 1996, pp. 1196-1203
Citation: G. Imanidis et al., INTESTINAL PERMEATION AND METABOLISM OF A MODEL PEPTIDE (LEUPROLIDE) AND MECHANISMS OF PERMEATION ENHANCEMENT BY NONIONIC SURFACTANTS, International journal of pharmaceutics, 120(1), 1995, pp. 41-50
Authors:
IMANIDIS G
SONG WQ
LEE PH
SU MH
KERN ER
HIGUCHI WI
Citation: G. Imanidis et al., ESTIMATION OF SKIN TARGET SITE ACYCLOVIR CONCENTRATIONS FOLLOWING CONTROLLED (TRANS)DERMAL DRUG-DELIVERY IN TOPICAL AND SYSTEMIC TREATMENT OF CUTANEOUS HSV-1 INFECTIONS IN HAIRLESS MICE, Pharmaceutical research, 11(7), 1994, pp. 1035-1041